PHARMACEUTICAL industry peak body Medicines Australia (MA) has said it warmly welcomes the commencement of The Bridge Program, an initiative of a consortium of Australian innovative pharmaceutical companies and MA, together with QUT and Medical Technologies and Pharmaceutical Growth Centre, who will "translate Australia's impressive innovation and discovery research into the marketplace".
The Bridge Program will commence in June this year for 100 participants and will also give two participants a travel scholarship to visit overseas pharmaceutical research facilities and develop global experience.
MA ceo Milton Catelin said, "Collaborative programs such as this one boost opportunities for commercialisation and investment, and sets the nation on a path to a more innovative and entrepreneurial economy."
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Apr 17
